NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

轉染的中東、非洲市場:產業趨勢與預測 (∼2028年)

Middle East and Africa Transfection Market - Industry Trends and Forecast to 2028

出版商 Data Bridge Market Research Private Limited 商品編碼 977684
出版日期 內容資訊 英文 100 Pages
商品交期: 3-5個工作天內
價格
轉染的中東、非洲市場:產業趨勢與預測 (∼2028年) Middle East and Africa Transfection Market - Industry Trends and Forecast to 2028
出版日期: 2020年11月01日內容資訊: 英文 100 Pages
簡介

中東、非洲的轉染的市場規模,預計從2020年到2027年的預測期間記錄9.6%的年複合成長率。

本報告提供中東、非洲的轉染市場相關調查,市場概要動態,各市場區隔、各地區的市場規模的分析與預測,並提供主要企業簡介等資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

  • TAM (Total Addressable Market)
    • 各手法/模式
    • 各終端用戶
    • 各應用領域
    • 各階段
  • 生物醫藥品的初期及後期階段的細胞株開發及基因治療的病毒載體生產
    • 用中國倉鼠卵巢(CHO)細胞生產的已通過核准抗體清單及哺乳類的表現媒介使用的可選擇的標記清單

第5章 法律規範

  • EU的法規方案
  • 美國的法規方案
  • 日本的法規方案
  • 中國的法規方案

第6章 市場概要

  • 促進因素
    • 慢性疾病的盛行率上升
    • 合成生物學產品的開發
    • 嵌合遺傳基因的需求高漲
    • 臨床研究所使用的大規模轉染
    • 蛋白質的產生的生物醫藥品的使用
  • 阻礙因素
    • 轉染產品的成本高
    • 轉染試劑的選擇中有效性
    • 轉染程序引起的細胞損傷
  • 市場機會
    • 新興市場開拓
    • 市場參與者的策略性舉措
    • 政府的輔助增加
    • 投資等級劇增
  • 課題
    • 長期批審
    • 缺乏病毒相關轉染用安全等級的實驗室
    • 熟練專家的不足

第7章 中東、非洲的醫療保健產業上轉染市場COVID-19的影響

  • 概要
  • 對價格的影響
  • 對需求的影響
  • 對供應鏈的影響
  • 製造商的策略性舉措
  • 結論

第8章 中東、非洲的轉染市場:各類型

  • 概要
  • 一時性轉染
    • 各階段
    • 各產品
  • 穩定轉染

第9章 中東、非洲的轉染市場:各手法

  • 概要
  • 非病毒性手法
    • 化學性
    • 物理性
  • 病毒法
    • 反轉錄病毒轉染
    • 腺病毒轉染
    • 慢病毒轉染
    • 其他

第10章 中東、非洲的轉染市場:各產品

  • 概要
  • 試劑&套件
    • 陽離子性脂質
    • 陽離子聚合物
    • 奈米粒子
    • 套件
    • CUVETTE CHAMBER
    • 其他
  • 設備
    • 電穿孔系統
    • 電電池單元fusion生成器
    • 動電學的轉染系統
    • HEPTA系統
    • 管材準備站
    • RT-PCR
    • 槍系統
    • 微量盤式分析儀
    • Sonoporation系統
    • 顯微鏡
    • 其他

第11章 中東、非洲的轉染市場:各生物

  • 概要
  • 哺乳類細胞
  • 植物
  • 菌類
  • 病毒
  • 細菌

第12章 中東、非洲的轉染市場:各分子類型

  • 概要
  • 質體DNA
  • 低分子干涉RNA(SIRNA)
  • 蛋白質
  • DNA寡核苷酸
  • RNP (RNA-肽複合體)
  • 其他

第13章 中東、非洲的轉染市場:各應用領域

  • 概要
  • 各類型
    • 體外應用
    • 體內應用
    • 生物生產
    • 其他
  • 各業界
    • 合成生物學
    • 農業
    • 其他

第14章 中東、非洲的轉染市場:各階段

  • 概要
  • 研究
  • 前臨床
  • 臨床階段
  • 商業

第15章 中東、非洲的轉染市場:各終端用戶

  • 概要
  • 生物醫藥品
  • 委託調查機關(CRO)
  • 契約製造組織/契約開發及製造組織(CMO/CDMO)
  • 大學
  • 醫院
  • 臨床實驗室
  • 其他

第16章 中東、非洲的轉染市場:各流通管道

  • 概要
  • 直接競標
  • 零售
  • 其他

第17章 中東、非洲的轉染市場:各地區

  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 埃及
    • 其他中東、非洲

第18章 中東、非洲的轉染市場:企業形勢

  • 企業佔有率分析:中東、非洲

第19章 SWOT分析

第20章 企業簡介

  • THERMOFISHER SCIENTIFIC INC.
  • ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
  • QIAGEN
  • PROMEGA CORPORATION
  • TAKARA BIO INC.
  • BIO-RAD LABORATORIES, INC.
  • LONZA
  • CYTIVA
  • ALTOGEN BIOSYSTEMS
  • AMYRIS
  • APPLIED BIOLOGICAL MATERIALS INC. (ABM)
  • AUTOLUS
  • AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
  • BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
  • CODEXIS
  • CONAGEN, INC.
  • FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
  • GENLANTIS INC.
  • GENO TECHNOLOGY INC., USA
  • GINKGO BIOWORKS
  • IMPOSSIBLE FOODS INC.
  • MAXCYTE, INC.
  • MERCK KGAA
  • MIRUS BIO LLC.
  • ORIGENE TECHNOLOGIES, INC.
  • PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
  • POLYPLUS TRANSFECTION
  • POSEIDA THERAPEUTICS, INC.
  • R&D SYSTEMS, INC.
  • SBS GENETECH
  • SIGNAGEN LABORATORIES
  • TWIST BIOSCIENCE
  • VERVE THERAPEUTICS, INC.
  • ZYMERGEN INC.

第21章 問卷調查

第22章 相關報告

目錄

Middle East and Africa transfection market is projected to register a healthy CAGR of 9.6% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Middle East and Africa Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Saudi Arabia, South Africa, UAE, Israel, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Some of the major factors contributing to the growth of Middle East and Africa transfection market are:

  • Large-scale transfections used in clinical research
  • Exploration of emerging market

Market Players

The key market players for Middle East and Africa transfection market are listed below:

  • Mirus Bio LLC.
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Lonza
  • MaxCyte, Inc.
  • Cytiva
  • Thermofisher Scientific Inc.
  • QIAGEN
  • OriGene Technologies, Inc.
  • SignaGen Laboratories

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA TRANSFECTION MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

  • 4.1 TOTAL ADDRESSABLE MARKET
    • 4.1.1 BY METHOD/MODALITY
    • 4.1.2 BY END USER
    • 4.1.3 BY APPLICATION
    • 4.1.4 BY STAGE
  • 4.2 EARLY AND LATE STAGE CELL LINE DEVELOPMENT FOR BIOPHARMA AND VIRAL VECTOR PRODUCTION FOR GENE THERAPY
    • 4.2.1 THE LIST OF APPROVED ANTIBODIES PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS AND LIST OF SELECTABLE MARKERS USED IN MAMMALIAN EXPRESSION VECTORS

5 REGULATORY FRAMEWORK

  • 5.1 EUROPEAN UNION REGULATORY SCENARIO
  • 5.2 U.S. REGULATORY SCENARIO
  • 5.3 JAPAN REGULATORY SCENARIO
  • 5.4 CHINA REGULATORY SCENARIO

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
    • 6.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
    • 6.1.3 GROWING DEMAND OF CHIMERIC GENES
    • 6.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
    • 6.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
  • 6.2 RESTRAINTS
    • 6.2.1 HIGH COST OF TRANSFECTION PRODUCTS
    • 6.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
    • 6.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
  • 6.3 OPPORTUNITIES
    • 6.3.1 EXPLORATION OF EMERGING MARKET
    • 6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
    • 6.3.3 INCREASING GOVERNMENT SUPPORT
    • 6.3.4 SURGING LEVEL OF INVESTMENT
  • 6.4 CHALLENGES
    • 6.4.1 LONG APPROVAL PROCEDURE
    • 6.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS ASSOCIATED TRANSFECTION
    • 6.4.3 LACK OF TRAINED PROFESSIONALS

7 COVID-19 IMPACT OF MIDDLE EAST AND AFRICA TRANSFECTION MARKET IN HEALTHCARE INDUSTRY

  • 7.1 OVERVIEW
  • 7.2 IMPACT ON THE PRICE
  • 7.3 IMPACT ON DEMAND
  • 7.4 IMPACT ON SUPPLY CHAIN
  • 7.5 STRATEGIC INITIATIVE BY MANUFACTURERS
  • 7.6 CONCLUSION

8 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY TYPE

  • 8.1 OVERVIEW
  • 8.2 TRANSIENT TRANSFECTION
    • 8.2.1 BY STAGE
      • 8.2.1.1 RESEARCH
      • 8.2.1.2 PRECLINICAL
      • 8.2.1.3 CLINICAL PHASES
      • 8.2.1.4 COMMERCIAL
    • 8.2.2 BY PRODUCT
      • 8.2.2.1 REAGENT & KITS
      • 8.2.2.2 INSTRUMENTS
      • 8.2.2.3 SOFTWARE
  • 8.3 STABLE TRANSECTION
    • 8.3.1 BY STAGE
      • 8.3.1.1 RESEARCH
      • 8.3.1.2 PRECLINICAL
      • 8.3.1.3 CLINICAL PHASES
      • 8.3.1.4 COMMERCIAL
    • 8.3.2 BY PRODUCT
      • 8.3.2.1 REAGENT & KITS
      • 8.3.2.2 INSTRUMENTS
      • 8.3.2.3 SOFTWARE

9 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY METHODS

  • 9.1 2.1 OVERVIEW
  • 9.2 NON- VIRAL METHODS
    • 9.2.1 CHEMICAL
      • 9.2.1.1 Lipofection Method
      • 9.2.1.2 Calcium Phosphate Precipitation Method
      • 9.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 9.2.1.4 Others
    • 9.2.2 PHYSICAL
      • 9.2.2.1 Electroporation
      • 9.2.2.2 Direct Microinjection
      • 9.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 9.2.2.4 Magnetofection
      • 9.2.2.5 Sonoporation
      • 9.2.2.6 Others
  • 9.3 VIRAL METHODS
    • 9.3.1 RETROVIRUS TRANSFECTION
    • 9.3.2 ADENOVIRUS TRANSFECTION
    • 9.3.3 LENTIVIRUS TRANSFECTION
    • 9.3.4 OTHERS

10 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY METHODS

  • 10.1 OVERVIEW
  • 10.2 NON- VIRAL METHODS
    • 10.2.1 CHEMICAL
      • 10.2.1.1 Lipofection Method
      • 10.2.1.2 Calcium Phosphate Precipitation Method
      • 10.2.1.3 Polyethylenimine (PEI)-DNA Condensation Method
      • 10.2.1.4 Others
    • 10.2.2 PHYSICAL
      • 10.2.2.1 Electroporation
      • 10.2.2.2 Direct Microinjection
      • 10.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
      • 10.2.2.4 Magnetofection
      • 10.2.2.5 Sonoporation
      • 10.2.2.6 Others
  • 10.3 VIRAL METHODS
    • 10.3.1 RETROVIRUS TRANSFECTION
    • 10.3.2 ADENOVIRUS TRANSFECTION
    • 10.3.3 LENTIVIRUS TRANSFECTION
    • 10.3.4 OTHERS

11 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY PRODUCTS

  • 11.1 OVERVIEW
  • 11.2 REAGENTS & KITS
    • 11.2.1 CATIONIC LIPIDS
      • 11.2.1.1 Liposomal Reagents
        • 11.2.1.1.1 L-Dioleoyl Phosphatidylethanolamine (DOPE)
        • 11.2.1.1.2 DOTAP [1,2-Dioleoyloxy-3-Trimethylammonium Propane]
        • 11.2.1.1.3 DOTMA [N-[1(2,3-Dioleoyloxy)Propyl]-N,N,N-Trimethylammonium Chloride]
        • 11.2.1.1.4 Others
      • 11.2.1.2 Non-Liposomal Reagents
        • 11.2.1.2.1 DNA Transfection Reagent
        • 11.2.1.2.2 siRNA Transfection Reagent
        • 11.2.1.2.3 Others
    • 11.2.2 CATIONIC POLYMER
      • 11.2.2.1 DEAE-Dextran
      • 11.2.2.2 Polybrene
      • 11.2.2.3 Polyethyleneimine
      • 11.2.2.4 Dendrimers
      • 11.2.2.5 Others
    • 11.2.3 NANOPARTICLES
      • 11.2.3.1 Systemic Intravenous Injection
      • 11.2.3.2 Direct Intratumoral Injection
    • 11.2.4 KITS
      • 11.2.4.1 Transporter Transfection Reagent
      • 11.2.4.2 GMP Transfection Reagent
      • 11.2.4.3 Neon Electroporation
      • 11.2.4.4 Cellfectin Ii Transfection Reagent
      • 11.2.4.5 DMRIE-C Transfection Reagent
      • 11.2.4.6 Lipofectamine Transfection Reagent
      • 11.2.4.7 Lipofectin Transfection Reagent
      • 11.2.4.8 Oligofectamine Transfection Reagent
      • 11.2.4.9 Optifect Transfection Reagent
      • 11.2.4.10 Cell Specific Transfection Reagent
      • 11.2.4.11 Gene Gun Kit
      • 11.2.4.12 Plasmid Transfection Reagent
      • 11.2.4.13 Others
    • 11.2.5 CUVETTE CHAMBER
    • 11.2.6 OTHERS
  • 11.3 INSTRUMENT
    • 11.3.1 ELECTROPORATION SYSTEM
      • 11.3.1.1 Neon Transfection System
      • 11.3.1.2 Others
    • 11.3.2 ELECTRO-CELL FUSION GENERATOR
    • 11.3.3 ELECTRO-KINETIC TRANSFECTION SYSTEM
    • 11.3.4 HEPTA SYSTEM
    • 11.3.5 TUBING PREP STATION
    • 11.3.6 RT-PCR
    • 11.3.7 GUN SYSTEM
    • 11.3.8 MICROPLATE READER
    • 11.3.9 SONOPORATION SYSTEM
    • 11.3.10 MICROSCOPES
    • 11.3.11 OTHERS

12 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY ORGANISM

  • 12.1 OVERVIEW
  • 12.2 MAMMALIAN CELLS
  • 12.3 PLANTS
  • 12.4 FUNGI
  • 12.5 VIRUS
  • 12.6 BACTERIA

13 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE

  • 13.1 OVERVIEW
  • 13.2 PLASMID DNA
  • 13.3 SMALL INTERFERING RNA (SIRNA)
  • 13.4 PROTEINS
  • 13.5 DNA OLIGONUCLEOTIDES
  • 13.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
  • 13.7 OTHERS

14 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY APPLICATION

  • 14.1 OVERVIEW
  • 14.2 BY TYPE
    • 14.2.1 IN VITRO APPLICATION
      • 14.2.1.1 Gene Expression
      • 14.2.1.2 RNA Interference
    • 14.2.2 IN VIVO APPLICATION
      • 14.2.2.1 Gene Therapy
      • 14.2.2.2 Cellular-Based Therapy
    • 14.2.3 BIOPRODUCTION
      • 14.2.3.1 Antibody/Protein Production
      • 14.2.3.2 Virus Production
    • 14.2.4 OTHERS
  • 14.3 BY INDUSTRY
    • 14.3.1 SYNTHETIC BIOLOGY
      • 14.3.1.1 Biopharma
      • 14.3.1.2 Monoclonal Antibodies (mAbs)
      • 14.3.1.3 Recombinant Proteins
      • 14.3.1.4 Biofuels
      • 14.3.1.5 Cell Line Development
      • 14.3.1.6 Flavors & Fragrances
      • 14.3.1.7 Enzyme Engineering & Production
      • 14.3.1.8 Specialty Chemicals
    • 14.3.2 AGRICULTURE
    • 14.3.3 OTHERS

15 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY STAGES

  • 15.1 OVERVIEW
  • 15.2 RESEARCH
  • 15.3 PRECLINICAL
  • 15.4 CLINICAL PHASES
  • 15.5 COMMERCIAL

16 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY END USER

  • 16.1 OVERVIEW
  • 16.2 BIOPHARMA
  • 16.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 16.4 CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS)
  • 16.5 ACADEMIA
  • 16.6 HOSPITALS
  • 16.7 CLINICAL LABS
  • 16.8 OTHERS

17 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL

  • 17.1 OVERVIEW
  • 17.2 DIRECT TENDERS
  • 17.3 RETAIL SALES
  • 17.4 OTHERS

18 MIDDLE EAST AND AFRICA TRASNFECTION MARKET, BY GEOGRAPHY

  • 18.1 MIDDLE EAST & AFRICA
    • 18.1.1 SOUTH AFRICA
    • 18.1.2 SAUDI ARABIA
    • 18.1.3 UAE
    • 18.1.4 ISRAEL
    • 18.1.5 EGYPT
    • 18.1.6 REST OF MIDDLE EAST & AFRICA

19 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: COMPANY LANDSCAPE

  • 19.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

20 SWOT ANALYSIS

21 COMPANY PROFILE

  • 21.1 THERMOFISHER SCIENTIFIC INC.
    • 21.1.1 COMPANY SNAPSHOT
    • 21.1.2 REVENUE ANALYSIS
    • 21.1.3 COMPANY SHARE ANALYSIS
    • 21.1.4 PRODUCT PORTFOLIO
    • 21.1.5 RECENT DEVELOPMENTS
  • 21.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
    • 21.2.1 COMPANY SNAPSHOT
    • 21.2.2 REVENUE ANALYSIS
    • 21.2.3 COMAPYN SHARE ANALYSIS
    • 21.2.4 PRODUCT PORTFOLIO
    • 21.2.5 RECENT DEVELOPMENTS
  • 21.3 QIAGEN
    • 21.3.1 COMPANY SNAPSHOT
    • 21.3.2 REVENUE ANALYSIS
    • 21.3.3 COMPANY SHARE ANALYSIS
    • 21.3.4 PRODUCT PORTFOLIO
    • 21.3.5 RECENT DEVELOPMENTS
  • 21.4 PROMEGA CORPORATION
    • 21.4.1 COMPANY SNAPSHOT
    • 21.4.2 COMPANY SHARE ANALYSIS
    • 21.4.3 PRODUCT PORTFOLIO
    • 21.4.4 RECENT DEVELOPMENTS
  • 21.5 TAKARA BIO INC.
    • 21.5.1 COMPANY SNAPSHOT
    • 21.5.2 REVENUE ANALYSIS
    • 21.5.3 COMPANY SHARE ANALYSIS
    • 21.5.4 PRODUCT PORTFOLIO
    • 21.5.5 RECENT DEVELOPMENTS
  • 21.6 BIO-RAD LABORATORIES, INC.
    • 21.6.1 COMPANY SNAPSHOT
    • 21.6.2 REVENUE ANANLYSIS
    • 21.6.3 PRODUCT PORTFOLIO
    • 21.6.4 RECENT DEVELOPMENT
  • 21.7 LONZA
    • 21.7.1 COMPANY SNAPSHOT
    • 21.7.2 REVENUE ANANLYSIS
    • 21.7.3 PRODUCT PORTFOLIO
    • 21.7.4 RECENT DEVELOPMENTS
  • 21.8 CYTIVA
    • 21.8.1 COMPANY SNAPSHOT
    • 21.8.2 PRODUCT PORTFOLIO
    • 21.8.3 RECENT DEVELOPMENTS
  • 21.9 ALTOGEN BIOSYSTEMS
    • 21.9.1 COMPANY SNAPSHOT
    • 21.9.2 PRODUCT PORTFOLIO
    • 21.9.3 RECENT DEVELOPMENTS
  • 21.10 AMYRIS
    • 21.10.1 COMPANY SNAPSHOT
    • 21.10.2 REVENUE ANALYSIS
    • 21.10.3 PRODUCT PORTFOLIO
    • 21.10.4 RECENT DEVELOPMENTS
  • 21.11 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
    • 21.11.1 COMPANY SNAPSHOT
    • 21.11.2 PRODUCT PORTFOLIO
    • 21.11.3 RECENT DEVELOPMENT
  • 21.12 AUTOLUS
    • 21.12.1 COMPANY SNAPSHOT
    • 21.12.2 PRODUCT PORTFOLIO
    • 21.12.3 RECENT DEVELOPMENTS
  • 21.13 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
    • 21.13.1 COMPANY SNAPSHOT
    • 21.13.2 REVENUE ANALYSIS
    • 21.13.3 PRODUCT PORTFOLIO
    • 21.13.4 RECENT DEVELOPMENT
  • 21.14 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
    • 21.14.1 COMPANY SNAPSHOT
    • 21.14.2 REVENUE ANALYSIS
    • 21.14.3 PRODUCT PORTFOLIO
    • 21.14.4 RECENT DEVELOPMENTS
  • 21.15 CODEXIS
    • 21.15.1 COMPANY SNAPSHOT
    • 21.15.2 REVENUE ANALYSIS
    • 21.15.3 PRODUCT PORTFOLIO
    • 21.15.4 RECENT DEVELOPMENTS
  • 21.16 CONAGEN, INC.
    • 21.16.1 COMPANY SNAPSHOT
    • 21.16.2 PRODUCT PORTFOLIO
    • 21.16.3 RECENT DEVELOPMENTS
  • 21.17 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
    • 21.17.1 COMPANY SNAPSHOT
    • 21.17.2 REVENUE ANANLYSIS
    • 21.17.3 PRODUCT PORTFOLIO
    • 21.17.4 RECENT DEVELOPMENT
  • 21.18 GENLANTIS INC.
    • 21.18.1 COMPANY SNAPSHOT
    • 21.18.2 PRODUCT PORTFOLIO
    • 21.18.3 RECENT DEVELOPMENTS
  • 21.19 GENO TECHNOLOGY INC., USA
    • 21.19.1 COMPANY SNAPSHOT
    • 21.19.2 PRODUCT PORTFOLIO
    • 21.19.3 RECENT DEVELOPMENTS
  • 21.20 GINKGO BIOWORKS
    • 21.20.1 COMPANY SNAPSHOT
    • 21.20.2 PRODUCT PORTFOLIO
    • 21.20.3 RECENT DEVELOPMENTS
  • 21.21 IMPOSSIBLE FOODS INC.
    • 21.21.1 COMPANY SNAPSHOT
    • 21.21.2 PRODUCT PORTFOLIO
    • 21.21.3 RECENT DEVELOPMENTS
  • 21.22 MAXCYTE, INC.
    • 21.22.1 COMPANY SNAPSHOT
    • 21.22.2 REVENUE ANALYSIS
    • 21.22.3 PRODUCT PORTFOLIO
    • 21.22.4 RECENT DEVELOPMENTS
  • 21.23 MERCK KGAA
    • 21.23.1 COMPANY SNAPSHOT
    • 21.23.2 REVENUE ANALYSIS
    • 21.23.3 PRODUCT PORTFOLIO
    • 21.23.4 RECENT DEVELOPMENTS
  • 21.24 MIRUS BIO LLC.
    • 21.24.1 COMPANY SNAPSHOT
    • 21.24.2 PRODUCT PORTFOLIO
    • 21.24.3 RECENT DEVELOPMENTS
  • 21.25 ORIGENE TECHNOLOGIES, INC.
    • 21.25.1 COMPANY SNAPSHOT
    • 21.25.2 PRODUCT PORTFOLIO
    • 21.25.3 RECENT DEVELOPMENTS
  • 21.26 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
    • 21.26.1 COMPANY SNAPSHOT
    • 21.26.2 REVENUE ANANLYSIS
    • 21.26.3 PRODUCT PORTFOLIO
    • 21.26.4 RECENT DEVELOPMENTS
  • 21.27 POLYPLUS TRANSFECTION
    • 21.27.1 COMPANY SNAPSHOT
    • 21.27.2 PRODUCT PORTFOLIO
    • 21.27.3 RECENT DEVELOPMENTS
  • 21.28 POSEIDA THERAPEUTICS, INC.
    • 21.28.1 COMPANY SNAPSHOT
    • 21.28.2 PRODUCT PORTFOLIO
    • 21.28.3 RECENT DEVELOPMENTS
  • 21.29 R&D SYSTEMS, INC.
    • 21.29.1 COMPANY SNAPSHOT
    • 21.29.2 PRODUCT PORTFOLIO
    • 21.29.3 RECENT DEVELOPMENT
  • 21.30 SBS GENETECH
    • 21.30.1 COMPANY SNAPSHOT
    • 21.30.2 PRODUCT PORTFOLIO
    • 21.30.3 RECENT DEVELOPMENTS
  • 21.31 SIGNAGEN LABORATORIES
    • 21.31.1 COMPANY SNAPSHOT
    • 21.31.2 PRODUCT PORTFOLIO
    • 21.31.3 RECENT DEVELOPMENTS
  • 21.32 TWIST BIOSCIENCE
    • 21.32.1 COMPANY SNAPSHOT
    • 21.32.2 REVENUE ANALYSIS
    • 21.32.3 PRODUCT PORTFOLIO
    • 21.32.4 RECENT DEVELOPMENTS
  • 21.33 VERVE THERAPEUTICS, INC.
    • 21.33.1 COMPANY SNAPSHOT
    • 21.33.2 PRODUCT PORTFOLIO
    • 21.33.3 RECENT DEVELOPMENTS
  • 21.34 ZYMERGEN INC.
    • 21.34.1 COMPANY SNAPSHOT
    • 21.34.2 PRODUCT PORTFOLIO
    • 21.34.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS
  • TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS
  • TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES
  • TABLE 4 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 5 MIDDLE EAST AND AFRICA TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 6 MIDDLE EAST AND AFRICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 16 MIDDLE EAST AND AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 31 MIDDLE EAST AND AFRICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 32 MIDDLE EAST AND AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 33 MIDDLE EAST AND AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 34 MIDDLE EAST AND AFRICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 35 MIDDLE EAST AND AFRICA SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 37 MIDDLE EAST AND AFRICA MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 MIDDLE EAST AND AFRICA PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 45 MIDDLE EAST AND AFRICA PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 46 MIDDLE EAST AND AFRICA DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 47 MIDDLE EAST AND AFRICA RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 48 MIDDLE EAST AND AFRICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 49 MIDDLE EAST AND AFRICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 50 MIDDLE EAST AND AFRICA IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 52 MIDDLE EAST AND AFRICA IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 MIDDLE EAST AND AFRICA BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 56 MIDDLE EAST AND AFRICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 57 MIDDLE EAST AND AFRICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 58 MIDDLE EAST AND AFRICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 60 MIDDLE EAST AND AFRICA AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 61 MIDDLE EAST AND AFRICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 63 MIDDLE EAST AND AFRICA RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 64 MIDDLE EAST AND AFRICA PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 65 MIDDLE EAST AND AFRICA CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 66 MIDDLE EAST AND AFRICA COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 68 MIDDLE EAST AND AFRICA BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 69 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 70 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 71 MIDDLE EAST AND AFRICA ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 72 MIDDLE EAST AND AFRICA HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 73 MIDDLE EAST AND AFRICA CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 74 MIDDLE EAST AND AFRICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 76 MIDDLE EAST AND AFRICA DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 77 MIDDLE EAST AND AFRICA RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 78 MIDDLE EAST AND AFRICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 79 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 81 MIDDLE EAST & AFRICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 82 MIDDLE EAST & AFRICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 83 MIDDLE EAST & AFRICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 84 MIDDLE EAST & AFRICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 88 MIDDLE EAST & AFRICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 89 MIDDLE EAST & AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 91 MIDDLE EAST & AFRICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 95 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 96 MIDDLE EAST & AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 97 MIDDLE EAST & AFRICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 98 MIDDLE EAST & AFRICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 100 MIDDLE EAST & AFRICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 101 MIDDLE EAST & AFRICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 102 MIDDLE EAST & AFRICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 103 MIDDLE EAST & AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 104 MIDDLE EAST & AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 105 MIDDLE EAST & AFRICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 115 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 116 MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 117 SOUTH AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 118 SOUTH AFRICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 119 SOUTH AFRICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 120 SOUTH AFRICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 121 SOUTH AFRICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 122 SOUTH AFRICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 123 SOUTH AFRICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 124 SOUTH AFRICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 125 SOUTH AFRICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 126 SOUTH AFRICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 127 SOUTH AFRICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 128 SOUTH AFRICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 129 SOUTH AFRICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 130 SOUTH AFRICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 131 SOUTH AFRICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 132 SOUTH AFRICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 133 SOUTH AFRICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 134 SOUTH AFRICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 135 SOUTH AFRICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 136 SOUTH AFRICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 137 SOUTH AFRICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 138 SOUTH AFRICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 139 SOUTH AFRICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 140 SOUTH AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 141 SOUTH AFRICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 142 SOUTH AFRICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 143 SOUTH AFRICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 144 SOUTH AFRICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 145 SOUTH AFRICA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 146 SOUTH AFRICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 147 SOUTH AFRICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 148 SOUTH AFRICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 149 SOUTH AFRICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 150 SOUTH AFRICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 151 SOUTH AFRICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 152 SOUTH AFRICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 153 SOUTH AFRICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 154 SAUDI ARABIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 155 SAUDI ARABIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 156 SAUDI ARABIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 157 SAUDI ARABIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 158 SAUDI ARABIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 159 SAUDI ARABIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 160 SAUDI ARABIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 161 SAUDI ARABIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 162 SAUDI ARABIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 163 SAUDI ARABIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 164 SAUDI ARABIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 165 SAUDI ARABIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 166 SAUDI ARABIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 167 SAUDI ARABIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 168 SAUDI ARABIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 169 SAUDI ARABIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 170 SAUDI ARABIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 171 SAUDI ARABIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 172 SAUDI ARABIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 173 SAUDI ARABIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 174 SAUDI ARABIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 175 SAUDI ARABIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 176 SAUDI ARABIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 177 SAUDI ARABIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 178 SAUDI ARABIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 179 SAUDI ARABIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 180 SAUDI ARABIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 181 SAUDI ARABIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 182 SAUDI ARABIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 183 SAUDI ARABIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 184 SAUDI ARABIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 185 SAUDI ARABIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 186 SAUDI ARABIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 187 SAUDI ARABIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 188 SAUDI ARABIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 189 SAUDI ARABIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 190 SAUDI ARABIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 191 UAE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 192 UAE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 193 UAE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 194 UAE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 195 UAE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 196 UAE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 197 UAE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 198 UAE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 199 UAE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 200 UAE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 201 UAE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 202 UAE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 203 UAE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 204 UAE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 205 UAE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 206 UAE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 207 UAE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 208 UAE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 209 UAE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 210 UAE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 211 UAE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 212 UAE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 213 UAE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 214 UAE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 215 UAE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 216 UAE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 217 UAE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 218 UAE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 219 UAE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 220 UAE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 221 UAE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 222 UAE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 223 UAE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 224 UAE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 225 UAE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 226 UAE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 227 UAE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 228 ISRAEL TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 229 ISRAEL TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 230 ISRAEL TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 231 ISRAEL STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 232 ISRAEL STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 233 ISRAEL TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 234 ISRAEL NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 235 ISRAEL CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 236 ISRAEL PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 237 ISRAEL VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 238 ISRAEL CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 239 ISRAEL NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 240 ISRAEL CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 241 ISRAEL PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 242 ISRAEL VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 243 ISRAEL TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 244 ISRAEL REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 245 ISRAEL CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 246 ISRAEL LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 247 ISRAEL NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 248 ISRAEL CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 249 ISRAEL KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 250 ISRAEL NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 251 ISRAEL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 252 ISRAEL INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 253 ISRAEL ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 254 ISRAEL TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 255 ISRAEL TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 256 ISRAEL TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 257 ISRAEL IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 258 ISRAEL IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 259 ISRAEL BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 260 ISRAEL TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 261 ISRAEL SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 262 ISRAEL TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 263 ISRAEL TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 264 ISRAEL TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 265 EGYPT TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
  • TABLE 266 EGYPT TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 267 EGYPT TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 268 EGYPT STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 269 EGYPT STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
  • TABLE 270 EGYPT TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 271 EGYPT NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 272 EGYPT CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 273 EGYPT PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 274 EGYPT VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 275 EGYPT CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 276 EGYPT NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 277 EGYPT CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 278 EGYPT PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 279 EGYPT VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
  • TABLE 280 EGYPT TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 281 EGYPT REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 282 EGYPT CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 283 EGYPT LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 284 EGYPT NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 285 EGYPT CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 286 EGYPT KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 287 EGYPT NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 288 EGYPT INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 289 EGYPT INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
  • TABLE 290 EGYPT ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
  • TABLE 291 EGYPT TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
  • TABLE 292 EGYPT TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
  • TABLE 293 EGYPT TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 294 EGYPT IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 295 EGYPT IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 296 EGYPT BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 297 EGYPT TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 298 EGYPT SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 299 EGYPT TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
  • TABLE 300 EGYPT TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 301 EGYPT TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 302 REST OF MIDDLE EAST & AFRICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: SEGMENTATION
  • FIGURE 2 MIDDLE EAST AND AFRICA TRANSFECTION MARKET : DATA TRIANGULATION
  • FIGURE 3 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 10 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: SEGMENTATION
  • FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE MIDDLE EAST AND AFRICA TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 13 TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA TRANSFECTION MARKET IN 2021 & 2028
  • FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA TRANSFECTION MARKET
  • FIGURE 16 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPE, 2020
  • FIGURE 17 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPE, 2020-2028 (USD MILLION)
  • FIGURE 18 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPE, CAGR (2021-2028)
  • FIGURE 19 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 20 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, 2020
  • FIGURE 21 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
  • FIGURE 22 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
  • FIGURE 23 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
  • FIGURE 24 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, 2020
  • FIGURE 25 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
  • FIGURE 26 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
  • FIGURE 27 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
  • FIGURE 28 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY PRODUCT, 2020
  • FIGURE 29 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY PRODUCT, 2020-2028 (USD MILLION)
  • FIGURE 30 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY PRODUCT, CAGR (2021-2028)
  • FIGURE 31 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY PRODUCT, LIFELINE CURVE
  • FIGURE 32 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY ORGANISM, 2020
  • FIGURE 33 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY ORGANISM, 2020-2028 (USD MILLION)
  • FIGURE 34 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY ORGANISM, CAGR (2021-2028)
  • FIGURE 35 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY ORGANISM, LIFELINE CURVE
  • FIGURE 36 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020
  • FIGURE 37 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020-2028 (USD MILLION)
  • FIGURE 38 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPES OF MOLECULE, CAGR (2021-2028)
  • FIGURE 39 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY TYPES OF MOLECULE LIFELINE CURVE
  • FIGURE 40 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY APPLICATION, 2020
  • FIGURE 41 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
  • FIGURE 42 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 43 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 44 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY STAGES, 2020
  • FIGURE 45 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY STAGES, 2020-2028 (USD MILLION)
  • FIGURE 46 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY STAGES, CAGR (2021-2028)
  • FIGURE 47 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY STAGES, LIFELINE CURVE
  • FIGURE 48 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY END USER, 2020
  • FIGURE 49 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY END USER, 2020-2028 (USD MILLION)
  • FIGURE 50 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 51 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 52 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 53 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
  • FIGURE 54 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 55 MIDDLE EAST AND AFRICA TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 56 MIDDLE EAST & AFRICA TRANSFECTION MARKET: SNAPSHOT (2020)
  • FIGURE 57 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2020)
  • FIGURE 58 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 59 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 60 MIDDLE EAST & AFRICA TRANSFECTION MARKET: BY TYPE (2021-2028)